Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study-Reference-Cited by-同舟云学术

Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study

Published:2016-11-17 Issue:2 Volume:22 Page:387-396
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hori Hiroki, ,Kudoh Tooru,Nishimura Shinichiro,Oda Megumi,Yoshida Makoto,Hara Junichi,Tawa Akio,Usami Ikuya,Tanizawa Akihiko,Yumura-Yagi Keiko,Kato Koji,Kobayashi Ryoji,Komada Yoshihiro,Matsuo Keitaro,Horibe Keizo

Funder

a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-016-1062-1.pdf

Reference30 articles.

1. Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541–1552

2. Hitchcock-Bryan S, Gelber R, Cassady JR et al (1986) The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 14:211–215

3. Lipshultz SE, Lipsitz SR, Sallan SE et al (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629–2636